Cargando…

Further rationale for optimal combined modality treatments

Detalles Bibliográficos
Autores principales:	Griffin, Robert J., Dings, Ruud P.M., Makhoul, Issam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432217/ https://www.ncbi.nlm.nih.gov/pubmed/28415727 http://dx.doi.org/10.18632/oncotarget.16117

Ejemplares similares

Further events are run in a virtual format
Publicado: (2020)

Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models
por: Koonce, Nathan A., et al.
Publicado: (2017)

The integrating nutritional therapy in oncology (INTO) project: rationale, structure and preliminary results
por: Caccialanza, Riccardo, et al.
Publicado: (2017)

Spectroscopic investigation of radiation-induced reoxygenation in radiation-resistant tumors
por: Dadgar, Sina, et al.
Publicado: (2020)

Enhanced Photothermal Treatment Efficacy and Normal Tissue Protection via Vascular Targeted Gold Nanocages
por: Jenkins, Samir V., et al.
Publicado: (2019)

Hypoxia-derived exosomes induce putative altered pathways in biosynthesis and ion regulatory channels in glioblastoma cells
por: Kore, Rajshekhar A., et al.
Publicado: (2018)

... ALICE forges ahead with further detectors
Publicado: (2006)

CSCs: regenerating optimism for osteosarcoma treatment
por: Levin, Adam S.
Publicado: (2018)

Galectins as Molecular Targets for Therapeutic Intervention
por: Dings, Ruud P. M., et al.
Publicado: (2018)

Optimal Lipid Modification: The Rationale for Combination Therapy
por: Backes, James M, et al.
Publicado: (2005)

Simulating cellular galectin networks by mixing galectins in vitro reveals synergistic activity
por: Dings, Ruud P.M., et al.
Publicado: (2021)

Rationale for Further Medical and Health Research on High-Potency Sweeteners
por: Schiffman, Susan S.
Publicado: (2012)

On optimizing therapies, Orai, and ORNs
por: Adler, Elizabeth M.
Publicado: (2013)

In memory of Michael J. O. Wakelam (1955–2020): a pioneer in lipid signalling and lipidomics
por: Griffin, Julian L.
Publicado: (2020)

“MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
por: Kory, Pierre, et al.
Publicado: (2022)

Combination strategies enhance oncolytic virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2017)

Combination immunotherapy for cancer
por: Fearon, Douglas
Publicado: (2016)

Rationale for Further Development of a Vaccine Based on the Circumsporozoite Protein of Plasmodium vivax
por: Yadava, Anjali, et al.
Publicado: (2017)

Sample storage conditions induce post-collection biases in microbiome profiles
por: Jenkins, Samir V., et al.
Publicado: (2018)

Developing and employing ideal teams for optimal global health outcomes
por: Perez, Casey, et al.
Publicado: (2021)

Schema therapy for Dissociative Identity Disorder (DID): further explanation about the rationale and study protocol
por: Huntjens, Rafaële J. C., et al.
Publicado: (2019)

Further considerations on the RF-System
por: Griffin, J
Publicado: (1987)

Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma
por: Bailey, Kelly M.
Publicado: (2018)

Further optimization of the VELO material
por: Dijkstra, H, et al.
Publicado: (2001)

Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further research
por: Chertoff, Jason, et al.
Publicado: (2015)

Optical imaging of radiation-induced metabolic changes in radiation-sensitive and resistant cancer cells
por: Alhallak, Kinan, et al.
Publicado: (2017)

CANCER: First Combined Analysis from INTERPHONE Inconclusive
por: Betts, Kellyn S.
Publicado: (2010)

Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities—a practical review
por: Hermans, Cedric, et al.
Publicado: (2020)

Search engine optimization for scientific publications: How one can find your needle in the haystack
por: Brouwer, Willem Pieter, et al.
Publicado: (2022)

Infections and neuropsychiatric disorders: new studies document pathways to prevention and treatment
por: Yolken, Robert
Publicado: (2023)

Exploring Modality Switching Effects in Negated Sentences: Further Evidence for Grounded Representations
por: Hald, Lea A., et al.
Publicado: (2013)

Selecting suitable chemotherapies for PD-1/PD-L1 blockade to optimize the tumor immune microenvironment
por: Koyama, Shohei, et al.
Publicado: (2018)

Further Studies on the Nutrition of Hemophilus Piscium
por: Griffin, Philip J.
Publicado: (1952)

New combinations in the treatment of COPD: rationale for aclidinium–formoterol
por: Incorvaia, Cristoforo, et al.
Publicado: (2016)

Mitochondrial Mix: Combined Approach to Visualizing Oxidative Stress in Real Time
por: Spivey, Angela
Publicado: (2010)

Drug repurposing using high-throughput screening identifies a promising drug combination to treat adrenocortical carcinoma
por: Lerario, Antonio M., et al.
Publicado: (2018)

ECHA ARN documents: chemical grouping without a toxicological rationale
por: Natsch, Andreas, et al.
Publicado: (2023)

Bringing the Bugs Back In: Environmental Health Research Model Combines Toxicology and Infectious Disease
por: Black, Harvey
Publicado: (2010)

CDK4/6 inhibition alone and in combination for non-small cell lung cancer
por: Pacheco, Jose, et al.
Publicado: (2019)

A Radiosensitizing Inhibitor of HIF-1 alters the Optical Redox State of Human Lung Cancer Cells In Vitro
por: Lee, David E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jeov7johcpjcnea4ou1m5njr94